Literature DB >> 10168159

Wound healing management: enhancing patient outcomes and reducing costs.

J V Boykin1, M C Crossland, L M Cole.   

Abstract

Biomedical technology as applied to wound healing management allows specific evaluations of the oxygen-related pathophysiology of non-healing wounds. In many of these cases the use of transcutaneous oxygen mapping of the skin and hyperbaric oxygen (HBO) therapy as an adjunctive treatment for non-healing wounds speeds the healing process. While HBO treatment has remained a covered service for hospital-based care, only recently have treatment algorithms for its application in an outpatient setting been available. This technological advancement has also been a factor in the development of cost effective wound healing centers (WHC) in community hospitals. Better outcomes for many chronic wounds are achieved by combining a multidisciplinary team approach using advanced technologies. In this article the case of a soft-tissue radiation necrosis ulceration of the leg successfully treated with adjunctive HBO is presented. In this example, a reduction in patient charges of greater than 30% was achieved as compared to costs associated with traditional surgical/hospital management of the condition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10168159

Source DB:  PubMed          Journal:  J Healthc Resour Manag        ISSN: 1078-9537


  3 in total

1.  Oxygen modulates the growth of skin fibroblasts.

Authors:  Arthur K Balin; Loretta Pratt
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-05       Impact factor: 2.416

2.  Effect of Hyperbaric Oxygen on Proliferation and Gene Expression of Human Chondrocytes: An In Vitro Study.

Authors:  Carolin Melcher; Birte Sievers; Nadine Höchsmann; Frank Düren; Volkmar Jansson; Peter E Müller
Journal:  Cartilage       Date:  2018-03-27       Impact factor: 4.634

3.  Hyperbaric oxygen therapy (HBOT) in case of hemorrhagic cystitis after radiotherapy.

Authors:  Wojciech Polom; Alicja Klejnotowska; Marcin Matuszewski; Zdzislaw Sicko; Marcin Markuszewski; Kazimierz Krajka
Journal:  Cent European J Urol       Date:  2012-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.